Published in Ann N Y Acad Sci on November 01, 2006
Fast feedback inhibition of the HPA axis by glucocorticoids is mediated by endocannabinoid signaling. Endocrinology (2010) 1.46
Annexin A2 at the interface of actin and membrane dynamics: a focus on its roles in endocytosis and cell polarization. Int J Cell Biol (2012) 1.17
Annexin 1 induced by anti-inflammatory drugs binds to NF-kappaB and inhibits its activation: anticancer effects in vitro and in vivo. Cancer Res (2010) 1.15
Tissue microarray analysis reveals strong clinical evidence for a close association between loss of annexin A1 expression and nodal metastasis in gastric cancer. Clin Exp Metastasis (2008) 1.06
Prolonged gaseous hypothermia prevents the upregulation of phagocytosis-specific protein annexin 1 and causes low-amplitude EEG activity in the aged rat brain after cerebral ischemia. J Cereb Blood Flow Metab (2012) 0.99
Annexin A1 and the regulation of innate and adaptive immunity. Front Immunol (2012) 0.94
Quantifying nonlinear interactions within the hypothalamo-pituitary-adrenal axis in the conscious horse. Endocrinology (2008) 0.93
Novel aspects of glucocorticoid actions. J Neuroendocrinol (2014) 0.89
Lysophosphatidic acid receptor activation affects the C13NJ microglia cell line proteome leading to alterations in glycolysis, motility, and cytoskeletal architecture. Proteomics (2010) 0.85
Nongenomic actions of adrenal steroids in the central nervous system. J Neuroendocrinol (2010) 0.84
Recurrent duplications of the annexin A1 gene (ANXA1) in autism spectrum disorders. Mol Autism (2014) 0.77
The anti-inflammatory Annexin A1 induces the clearance and degradation of the amyloid-β peptide. J Neuroinflammation (2016) 0.76
Annexin A1 translocates to nucleus and promotes the expression of pro-inflammatory cytokines in a PKC-dependent manner after OGD/R. Sci Rep (2016) 0.76
Overexpression of Annexin A1 Suppresses Pro-Inflammatory Factors in PC12 Cells Induced by 1-Methyl-4-Phenylpyridinium. Cell J (2016) 0.75
Reduced fear memory and anxiety-like behavior in mice lacking formylpeptide receptor 1. Behav Genet (2011) 0.75
A custom rat and baboon hypertension gene array to compare experimental models. Exp Biol Med (Maywood) (2012) 0.75
Annexins: from structure to function. Physiol Rev (2002) 6.78
Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity. Nature (1986) 4.57
Identification of chromaffin granule-binding proteins. Relationship of the chromobindins to calelectrin, synhibin, and the tyrosine kinase substrates p35 and p36. J Biol Chem (1987) 1.27
Post-translational modification plays an essential role in the translocation of annexin A1 from the cytoplasm to the cell surface. FASEB J (2006) 1.21
A calcium-driven conformational switch of the N-terminal and core domains of annexin A1. J Mol Biol (2003) 1.20
Lipocortin 1 mediates an early inhibitory action of glucocorticoids on the secretion of ACTH by the rat anterior pituitary gland in vitro. Neuroendocrinology (1993) 1.10
Correlation of gene and protein structure of rat and human lipocortin I. Biochemistry (1991) 1.03
Lipocortin 1: a second messenger of glucocorticoid action in the hypothalamo-pituitary-adrenocortical axis. Mol Med Today (1997) 1.02
Characterization and localization of lipocortin 1-binding sites on rat anterior pituitary cells by fluorescence-activated cell analysis/sorting and electron microscopy. Endocrinology (1997) 0.96
Glucocorticoids modulate the cellular disposition of lipocortin 1 in the rat brain in vivo and in vitro. Neuroreport (1997) 0.96
Annexin 1 and the regulation of endocrine function. Trends Endocrinol Metab (2004) 0.96
Lipocortin 1 (annexin 1): a candidate paracrine agent localized in pituitary folliculo-stellate cells. Endocrinology (1999) 0.95
Evidence for a role of the adenosine 5'-triphosphate-binding cassette transporter A1 in the externalization of annexin I from pituitary folliculo-stellate cells. Endocrinology (2003) 0.94
An antisense oligodeoxynucleotide to lipocortin 1 reverses the inhibitory actions of dexamethasone on the release of adrenocorticotropin from rat pituitary tissue in vitro. Endocrinology (1997) 0.93
Annexin 1-dependent actions of glucocorticoids in the anterior pituitary gland: roles of the N-terminal domain and protein kinase C. Endocrinology (2002) 0.92
Externalization of annexin I from a folliculo-stellate-like cell line. Endocrinology (2002) 0.92
Modulation of the hypothalamo-pituitary-adrenocortical responses to cytokines in the rat by lipocortin 1 and glucocorticoids: a role for lipocortin 1 in the feedback inhibition of CRF-41 release? Neuroendocrinology (1993) 0.90
Kinase-dependent regulation of the secretion of thyrotrophin and luteinizing hormone by glucocorticoids and annexin 1 peptides. J Neuroendocrinol (2003) 0.85
Evidence from studies on co-cultures of TtT/GF and AtT20 cells that Annexin 1 acts as a paracrine or juxtacrine mediator of the early inhibitory effects of glucocorticoids on ACTH release. J Neuroendocrinol (2003) 0.85
Perinatal glucocorticoid treatment produces molecular, functional, and morphological changes in the anterior pituitary gland of the adult male rat. Endocrinology (2005) 0.85
Mouse lipocortin I gene structure and chromosomal assignment: gene duplication and the origins of a gene family. Genomics (1991) 0.84
Annexin 1 (lipocortin 1) mediates the glucocorticoid inhibition of cyclic adenosine 3',5'-monophosphate-stimulated prolactin secretion. Endocrinology (2000) 0.83
Dexamethasone inhibits the release of TSH from the rat anterior pituitary gland in vitro by mechanisms dependent on de novo protein synthesis and lipocortin 1. J Endocrinol (1995) 0.82
Integration of biological networks and gene expression data using Cytoscape. Nat Protoc (2007) 27.10
Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. Nature (2009) 3.27
Inter-rater reliability of nursing home quality indicators in the U.S. BMC Health Serv Res (2003) 2.83
Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor. Nat Med (2002) 2.75
LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model. Hum Mol Genet (2009) 2.55
Aberrant inflammation and resistance to glucocorticoids in annexin 1-/- mouse. FASEB J (2002) 2.13
The quality of quality measurement in U.S. nursing homes. Gerontologist (2003) 2.04
Annexin 1: more than an anti-phospholipase protein. Inflamm Res (2004) 1.90
The progression of pathology in longitudinally followed patients with Parkinson's disease. Acta Neuropathol (2008) 1.80
Radiofrequency ablation and endoscopic mucosal resection for dysplastic barrett's esophagus and early esophageal adenocarcinoma: outcomes of the UK National Halo RFA Registry. Gastroenterology (2013) 1.77
Resolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: receptor-dependent actions. Arterioscler Thromb Vasc Biol (2012) 1.67
Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers. Vaccine (2009) 1.65
Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement. Blood (2005) 1.62
Leukocyte antiadhesive actions of annexin 1: ALXR- and FPR-related anti-inflammatory mechanisms. Blood (2003) 1.60
Cutting edge: Humanized nano-proresolving medicines mimic inflammation-resolution and enhance wound healing. J Immunol (2011) 1.52
Spatial and temporal profiles for anti-inflammatory gene expression in leukocytes during a resolving model of peritonitis. J Immunol (2006) 1.52
Intermittent intravenous pantoprazole and continuous cimetidine infusion: effect on gastric pH control in critically ill patients at risk of developing stress-related mucosal disease. J Trauma (2008) 1.51
Mental health and addiction workforce development: federal leadership is needed to address the growing crisis. Health Aff (Millwood) (2013) 1.50
SORL1 variants and risk of late-onset Alzheimer's disease. Neurobiol Dis (2007) 1.49
Ligand-specific conformational change of the G-protein-coupled receptor ALX/FPR2 determines proresolving functional responses. Proc Natl Acad Sci U S A (2013) 1.49
Role-play for medical students learning about communication: guidelines for maximising benefits. BMC Med Educ (2007) 1.47
Identification and evaluation of existing nursing homes quality indicators. Health Care Financ Rev (2002) 1.44
Annexin 1-deficient neutrophils exhibit enhanced transmigration in vivo and increased responsiveness in vitro. J Leukoc Biol (2005) 1.43
Modulation of inflammation and response to dexamethasone by Annexin 1 in antigen-induced arthritis. Arthritis Rheum (2004) 1.39
Progress on new vaccine strategies against chronic viral infections. J Clin Invest (2004) 1.38
Describing Activity in Primary Percutaneous Coronary Intervention: An Exploration of Denominators. From the HEAT Trial - A Systematic Evaluation of PPCI Activations in Liverpool, Explaining Denominators (HEAT-SEALED). J Invasive Cardiol (2016) 1.37
NCX-1015, a nitric-oxide derivative of prednisolone, enhances regulatory T cells in the lamina propria and protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice. Proc Natl Acad Sci U S A (2002) 1.36
Presynaptic NMDARs in the hippocampus facilitate transmitter release at theta frequency. Neuron (2010) 1.33
Critical protective role for annexin 1 gene expression in the endotoxemic murine microcirculation. Am J Pathol (2005) 1.27
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: THE INCREASING INCIDENCE OF THYROID CANCER. Endocr Pract (2015) 1.22
Activation of the annexin 1 counter-regulatory circuit affords protection in the mouse brain microcirculation. FASEB J (2007) 1.22
Development and preclinical evaluation of an alphavirus replicon particle vaccine for cytomegalovirus. Vaccine (2007) 1.19
Annexin A1: a central player in the anti-inflammatory and neuroprotective role of microglia. J Immunol (2010) 1.19
Annexin A1 regulates intestinal mucosal injury, inflammation, and repair. J Immunol (2008) 1.18
Activation of melanocortin type 3 receptor as a molecular mechanism for adrenocorticotropic hormone efficacy in gouty arthritis. Arthritis Rheum (2002) 1.15
The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier). Alzheimers Dement (2012) 1.14
Ligand-specific glucocorticoid receptor activation in human platelets. Blood (2005) 1.12
Attenuation of glucocorticoid functions in an Anx-A1-/- cell line. Biochem J (2003) 1.11
The impact of a normoglycemic management protocol on clinical outcomes in the trauma intensive care unit. JPEN J Parenter Enteral Nutr (2005) 1.11
Annexin-1 modulates T-cell activation and differentiation. Blood (2006) 1.10
Identifying the pattern of olfactory deficits in Parkinson disease using the brief smell identification test. Arch Neurol (2003) 1.10
Annexin 1 cleavage in activated neutrophils: a pivotal role for proteinase 3. J Biol Chem (2007) 1.10
Cellular and humoral immune responses to alphavirus replicon vaccines expressing cytomegalovirus pp65, IE1, and gB proteins. Clin Vaccine Immunol (2007) 1.08
An overview of the effects of annexin 1 on cells involved in the inflammatory process. Mem Inst Oswaldo Cruz (2005) 1.08
Molecular smallpox vaccine delivered by alphavirus replicons elicits protective immunity in mice and non-human primates. Vaccine (2009) 1.08
A pilot test of WebOSCE: a system for assessing trainees' clinical skills via teleconference. Med Teach (2002) 1.07
Risk of respiratory complications and wound infection in patients undergoing ambulatory surgery: smokers versus nonsmokers. Anesthesiology (2002) 1.06
Establishing a regional, multisite database for quality improvement and service planning in community-based palliative care and hospice. J Palliat Med (2010) 1.06
Stroke: working toward a prioritized world agenda. Stroke (2010) 1.05
Autosomal dominant growth hormone deficiency disrupts secretory vesicles in vitro and in vivo in transgenic mice. Endocrinology (2003) 1.05
Factors compromising safety in surgery: stressful events in the operating room. Am J Surg (2010) 1.05
Annexin-1 modulates repair of gastric mucosal injury. Am J Physiol Gastrointest Liver Physiol (2008) 1.03
The validity of a non-differential global positioning system for assessing player movement patterns in field hockey. J Sports Sci (2009) 1.01
Stroke: working toward a prioritized world agenda. Cerebrovasc Dis (2010) 1.01
Identification of an essential endogenous regulator of blood-brain barrier integrity, and its pathological and therapeutic implications. Proc Natl Acad Sci U S A (2012) 1.01
Annexin A1 in the brain--undiscovered roles? Trends Pharmacol Sci (2008) 1.00
Evidence for an anti-inflammatory loop centered on polymorphonuclear leukocyte formyl peptide receptor 2/lipoxin A4 receptor and operative in the inflamed microvasculature. J Immunol (2011) 1.00
Role of Annexin A1 in mouse myoblast cell differentiation. J Cell Physiol (2010) 1.00
The oral health of a group of prison inmates. Dent Update (2003) 1.00
Alphavirus replicon particles expressing TRP-2 provide potent therapeutic effect on melanoma through activation of humoral and cellular immunity. PLoS One (2010) 0.99
Impaired T cell activation and increased Th2 lineage commitment in Annexin-1-deficient T cells. Eur J Immunol (2007) 0.99
Existence of long-lasting experience-dependent plasticity in endocrine cell networks. Nat Commun (2012) 0.99
Functional and ultrastructural analysis of annexin A1 and its receptor in extravasating neutrophils during acute inflammation. Am J Pathol (2008) 0.99
Children's dental anxiety in the United Kingdom in 2003. J Dent (2008) 0.99
Multi-scale correlation structure of gene expression in the brain. Neural Netw (2011) 0.98
A vasculo-protective circuit centered on lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 operative in murine microcirculation. Blood (2013) 0.98
Potent antiarthritic properties of a glucocorticoid derivative, NCX-1015, in an experimental model of arthritis. Proc Natl Acad Sci U S A (2002) 0.97
Frontotemporal degeneration, the next therapeutic frontier: molecules and animal models for frontotemporal degeneration drug development. Alzheimers Dement (2012) 0.96
Impaired phagocytic mechanism in annexin 1 null macrophages. Br J Pharmacol (2006) 0.96
Natural orifice transluminal endoscopic surgery versus laparoscopic surgery for inadvertent colon injury repair: feasibility, risk of abdominal adhesions, and peritoneal contamination in a porcine survival model. Gastrointest Endosc (2010) 0.96
Annexin 1 and the regulation of endocrine function. Trends Endocrinol Metab (2004) 0.96
Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. Proc Natl Acad Sci U S A (2012) 0.95
A novel effect for annexin 1-derived peptide ac2-26: reduction of allergic inflammation in the rat. J Pharmacol Exp Ther (2005) 0.95
TRISS unexpected survivors: an outdated standard? J Trauma (2002) 0.94
Cellular in vivo imaging reveals coordinated regulation of pituitary microcirculation and GH cell network function. Proc Natl Acad Sci U S A (2010) 0.94
Antiallergic cromones inhibit neutrophil recruitment onto vascular endothelium via annexin-A1 mobilization. Arterioscler Thromb Vasc Biol (2010) 0.94
The amygdala and development of the social brain. Ann N Y Acad Sci (2003) 0.93
Correlation between the antiinflammatory protein annexin 1 (lipocortin 1) and serum cortisol in subjects with normal and dysregulated adrenal function. J Clin Endocrinol Metab (2004) 0.92
Annexin 1-dependent actions of glucocorticoids in the anterior pituitary gland: roles of the N-terminal domain and protein kinase C. Endocrinology (2002) 0.92
Expression, subcellular localization and phosphorylation status of annexins 1 and 5 in human pituitary adenomas and a growth hormone-secreting carcinoma. Clin Endocrinol (Oxf) (2004) 0.92
Attenuation of plasma annexin A1 in human obesity. FASEB J (2012) 0.91
Treatment of inflammatory diseases by selective eicosanoid inhibition: a double-edged sword? Trends Pharmacol Sci (2007) 0.90
The Imperial Stress Assessment Tool (ISAT): a feasible, reliable and valid approach to measuring stress in the operating room. World J Surg (2010) 0.89
Annexin A1 interaction with the FPR2/ALX receptor: identification of distinct domains and downstream associated signaling. J Biol Chem (2012) 0.89
Stimulus-specific defect in the phagocytic pathways of annexin 1 null macrophages. Br J Pharmacol (2004) 0.89
Cromoglycate drugs suppress eicosanoid generation in U937 cells by promoting the release of Anx-A1. Biochem Pharmacol (2009) 0.89
Annexin A1 regulates hormone exocytosis through a mechanism involving actin reorganization. FASEB J (2009) 0.89
Managing intraoperative stress: what do surgeons want from a crisis training program? Am J Surg (2009) 0.89
Annexin-1-deficient dendritic cells acquire a mature phenotype during differentiation. FASEB J (2008) 0.88